Although regular or prophylactic administration of G‐CSF to treat neutropenia was not performed in this trial, it is crucial to consider the timing of G‐CSF or PLAG administration in adjuvant chemotherapy to prevent associated neutropenia. Here, CSF3 is linked to Decreased total neutrophil count.